{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:31:22Z","timestamp":1773804682404,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":196,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2021]]},"DOI":"10.6061\/clinics\/2021\/e2643","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T08:55:31Z","timestamp":1626252931000},"page":"e2643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Increased Serum Interleukin-6 and Tumor Necrosis Factor Alpha Levels in Fabry Disease: Correlation with Disease Burden"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8457-5132","authenticated-orcid":false,"suffix":"Neto","given":"Nilton Salles","family":"Rosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3355-6895","authenticated-orcid":false,"given":"Judith Campos de Barros","family":"Bento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6606-8628","authenticated-orcid":false,"given":"Val\u00e9ria de Falco","family":"Caparbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3723-5028","authenticated-orcid":false,"given":"Rosa Maria Rodrigues","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.6061\/clinics\/2021\/e2643_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.6061\/clinics\/2021\/e2643_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-444-62702-5.00017-2","article-title":"Fabry disease","volume":"132","author":"Schiffmann","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.6061\/clinics\/2021\/e2643_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-020-03375-7","article-title":"Lysosome function in glomerular health and disease","author":"Meyer-Schwesinger","year":"2021","journal-title":"Cell Tissue Res"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2643_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2643_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-007-0296-4","article-title":"Immune system irregularities in lysosomal storage disorders","volume":"115","author":"Castaneda","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2643_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10545-008-1040-5","article-title":"Pathogenic cascades in lysosomal disease-Why so complex?","volume":"32","author":"Walkley","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.6061\/clinics\/2021\/e2643_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrgentox.2015.04.012","article-title":"DNA damage in Fabry patients: An investigation of oxidative damage and repair","volume":"784-785","author":"Biancini","year":"2015","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"10.6061\/clinics\/2021\/e2643_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2017.07.004","article-title":"Overview of immune abnormalities in lysosomal storage disorders","volume":"188","author":"Rigante","year":"2017","journal-title":"Immunol Lett"},{"key":"10.6061\/clinics\/2021\/e2643_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cca.2016.07.016","article-title":"Biomolecules damage and redox status abnormalities in Fabry patients before and during enzyme replacement therapy","volume":"461","author":"Biancini","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2643_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","article-title":"Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells","volume":"95","author":"Shen","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2643_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"DeGraba","year":"2000","journal-title":"Ann Neurol"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2643_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2011.06.007","article-title":"Higher apoptotic state in Fabry disease peripheral blood mononuclear cells: effect of globotriaosylceramide","volume":"104","author":"De Francesco","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"21","key":"10.6061\/clinics\/2021\/e2643_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009098","article-title":"Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction","volume":"7","author":"Yogasundaram","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.6061\/clinics\/2021\/e2643_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbadis.2011.11.001","article-title":"Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy","volume":"1822","author":"Biancini","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.6061\/clinics\/2021\/e2643_bib15","first-page":"1221.e1","article-title":"Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy","volume":"32","author":"Chen","year":"2016","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2643_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.6061\/clinics\/2021\/e2643_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ymgme.2019.05.009","article-title":"Tumor necrosis factor-\u03b1 links heat and inflammation with Fabry pain","volume":"127","author":"\u00dc\u00e7eyler","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2643_bib18","first-page":"271","article-title":"An association study of inflammatory cytokine gene polymorphisms in Fabry disease","volume":"17","author":"Safyan","year":"2006","journal-title":"Eur Cytokine Netw"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2643_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin Genet"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2643_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s42358-019-0111-7","article-title":"Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients","volume":"60","author":"Rosa Neto","year":"2020","journal-title":"Adv Rheumatol"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2021\/e2643_bib21","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s10545-009-1060-9","article-title":"Leukocyte perturbation associated with Fabry disease","volume":"32","author":"Rozenfeld","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.6061\/clinics\/2021\/e2643_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ymgme.2013.01.018","article-title":"Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease","volume":"108","author":"Pereira","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.6061\/clinics\/2021\/e2643_bib23","first-page":"1","article-title":"Innate and Adaptive Immune Response in Fabry Disease","volume":"22","author":"Mauhin","year":"2015","journal-title":"JIMD Rep"},{"issue":"6","key":"10.6061\/clinics\/2021\/e2643_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/CDLI.8.6.1097-1103.2001","article-title":"Comparison of serum and cell-specific cytokines in humans","volume":"8","author":"Jason","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.6061\/clinics\/2021\/e2643_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12877-018-0798-z","article-title":"Gender difference in the effects of interleukin-6 on grip strength - a systematic review and meta-analysis","volume":"18","author":"Mik\u00f3","year":"2018","journal-title":"BMC Geriatr"},{"issue":"5","key":"10.6061\/clinics\/2021\/e2643_bib26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ckj\/sfw082","article-title":"FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease","volume":"9","author":"Mignani","year":"2016","journal-title":"Clin Kidney J"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322200134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322200134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:51:25Z","timestamp":1761720685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S180759322200134X"},"secondary":[{"URL":"https:\/\/www.scielo.br\/j\/clin\/a\/sywWvRtD8V4ncVnMqXBbZhC\/?lang=en","label":"SCIELO"},{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8266164\/","label":"PMC"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/increased-serum-interleukin-6-and-tumor-necrosis-factor-alpha-levels-in-fabry-disease-correlation-with-disease-burden\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":26,"alternative-id":["S180759322200134X"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2021\/e2643","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Serum Interleukin-6 and Tumor Necrosis Factor Alpha Levels in Fabry Disease: Correlation with Disease Burden","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2021\/e2643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e2643"}}